Envista Holdings Corporation (NVST) Presents at Evercore 8th Annual Healthcare Conference Transcript
Envista Holdings Corporation (NVST) Presents at Evercore 8th Annual Healthcare Conference Transcript
Here's Why Envista (NVST) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Envista Holdings Corporation (NVST) Q3 2025 Earnings Call Transcript
Envista Holdings Corporation ( NVST ) Q3 2025 Earnings Call October 30, 2025 5:00 PM EDT Company Participants Jim Gustafson - Vice President of Investor Relations Paul Keel - CEO & Director Eric Hammes - Senior VP & CFO Conference Call Participants Allen Lutz - BofA Securities, Research Division Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Michael Cherny - Leerink Partners LLC, Research Division Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Linda Bolduc - Morgan Stanley, Research Division Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Steven Valiquette - Mizuho Securities USA LLC, Research Division Michael Sarcone - Jefferies LLC, Research Division Russell Yuen - William Blair & Company L.L.C.
Envista (NVST) Earnings Expected to Grow: Should You Buy?
Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Envista (NVST) Beat Estimates Again in Its Next Earnings Report?
Envista (NVST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Add NVST Stock to Your Portfolio Right Now
Envista's global expansion, strategic acquisitions, and solid solvency boost growth outlook despite FX headwinds.
NVST or ABT: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Products sector might want to consider either Envista (NVST) or Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?
Earnings Estimates Moving Higher for Envista (NVST): Time to Buy?
Envista (NVST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Why Envista (NVST) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
NVST vs. ABT: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?
Envista: Still Hold Rated, Near-Term Uncertainties Weighing On The Outlook
Envista's Q2 results showed broad-based growth, segment recovery, and improved margins, signaling early signs of stabilization and operational turnaround. Spark and implants businesses are rebounding, with Spark on track for profitability and cost efficiencies, and implants seeing sustained growth across regions. One-time revenue tailwinds, FX and tariff risks, and ongoing China uncertainty temper the near-term outlook and earnings growth potential.
